Literature DB >> 26758914

Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients.

Guillaume Dumas1, Anoosha Habibi2, Thierry Onimus3, Jean-Claude Merle4, Keyvan Razazi5, Armand Mekontso Dessap5, Frederic Galactéros6, Marc Michel1, Veronique Frémeaux Bacchi7, France Noizat Pirenne8, Pablo Bartolucci2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26758914     DOI： 10.1182/blood-2015-09-669770

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  21 in total

1.  Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease.

Authors:  Aline Floch; Alexandre Morel; Fabian Zanchetta-Balint; Catherine Cordonnier-Jourdin; Slimane Allali; Maximilien Grall; Ghislaine Ithier; Benjamin Carpentier; Sadaf Pakdaman; Jean-Claude Merle; Radjiv Goulabchand; Tackwa Khalifeh; Ana Berceanu; Cécile Helmer; Christelle Chantalat-Auger; Véronique Frémeaux-Bacchi; Marc Michel; Mariane de Montalembert; Armand Mekontso-Dessap; France Pirenne; Anoosha Habibi; Pablo Bartolucci
Journal:  Haematologica       Date:  2020-07-02       Impact factor: 9.941

2.  Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.

Authors:  Nicolas S Merle; Anne Grunenwald; Helena Rajaratnam; Viviane Gnemmi; Marie Frimat; Marie-Lucile Figueres; Samantha Knockaert; Sanah Bouzekri; Dominique Charue; Remi Noe; Tania Robe-Rybkine; Marie Le-Hoang; Nathan Brinkman; Thomas Gentinetta; Monika Edler; Sara Petrillo; Emanuela Tolosano; Sylvia Miescher; Sylvain Le Jeune; Pascal Houillier; Sophie Chauvet; Marion Rabant; Jordan D Dimitrov; Veronique Fremeaux-Bacchi; Olivier P Blanc-Brude; Lubka T Roumenina
Journal:  JCI Insight       Date:  2018-06-21

Review 3.  Management of hemolytic transfusion reactions.

Authors:  Jeanne E Hendrickson; Ross M Fasano
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

4.  Eculizumab as a Treatment for Hyper-Haemolytic and Aplastic Crisis in Sickle Cell Disease.

Authors:  Ishan Patel; Mihir Odak; Steven Douedi; Abbas Alshami; Vandan D Upadhyaya; Mohammad Hossain; Madhurima Anne; Swapnil V Patel
Journal:  Eur J Case Rep Intern Med       Date:  2021-08-07

Review 5.  How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.

Authors:  France Pirenne; Karina Yazdanbakhsh
Journal:  Blood       Date:  2018-05-03       Impact factor: 22.113

Review 6.  Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions.

Authors:  Connie M Arthur; Satheesh Chonat; Ross Fasano; Marianne E M Yee; Cassandra D Josephson; John D Roback; Sean R Stowell
Journal:  Transfus Med Rev       Date:  2019-10-18

Review 7.  Mechanisms of haemolysis-induced kidney injury.

Authors:  Kristof Van Avondt; Erfan Nur; Sacha Zeerleder
Journal:  Nat Rev Nephrol       Date:  2019-08-27       Impact factor: 28.314

8.  Delayed Severe Hemolytic Transfusion Reaction During Pregnancy in a Woman with β-Thalassemia Intermediate: Successful Outcome After Eculizumab Administration.

Authors:  Giovanna Cannas; Léa Dubreuil; Axel Fichez; Mathieu Gerfaud-Valentin; Anne-Lise Debard; Arnaud Hot
Journal:  Am J Case Rep       Date:  2021-05-13

9.  Post-transfusion hyperhemolysis syndrome in a patient with beta thalassemia major.

Authors:  Ganesh Kasinathan; Jameela Sathar
Journal:  Clin Case Rep       Date:  2021-06-22

Review 10.  Hyperhaemolytic Syndrome in Sickle Cell Disease: Clearing the Cobwebs.

Authors:  Anazoeze Jude Madu; Angela Ogechukwu Ugwu; Chilota Efobi
Journal:  Med Princ Pract       Date:  2020-11-11       Impact factor: 1.927
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.